660 — Wai Chun Bio Technology Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$17.15m
- HK$200.22m
- HK$773.65m
- 28
- 97
- 11
- 40
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 18 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -53 | 9.06 | 1.61 | 3.78 | -5.7 |
Depreciation | |||||
Non-Cash Items | 40.2 | 8.02 | 13 | 26.2 | 20.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2 | -8.15 | -21.4 | -41.4 | 20 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.13 | 14.3 | -0.413 | 4.78 | 48.9 |
Capital Expenditures | -6.56 | -13 | -12.5 | -16.8 | -28.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 4.06 | 0.184 | 0.026 | 0.136 | 0.038 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.5 | -12.8 | -12.5 | -16.7 | -28.1 |
Financing Cash Flow Items | -3.77 | -2.81 | -5.15 | -4.42 | -3.56 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.75 | -0.868 | 11.5 | 12.7 | -21.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.28 | 0.872 | 0.037 | 2.07 | -1.21 |